Home > Press > Iranian Scientists Use Nanodrugs to Treat Cancer
Abstract:
Iranian researchers from Tehran University of Medical Sciences studied the possibility of application of nanotechnology in targeted drug delivery systems to treat cancer.
Iranian Scientists Use Nanodrugs to Treat Cancer
Tehran, Iran | Posted on November 11th, 2014 This research studied the production of a nanodrug and its effects on the treatment of breast cancer.
The aim of the researchers was to present curcumin nanodrug with a slow and effective release pattern to heal breast cancer. Curcumin is a drug with anti-cancer and anti-inflammation properties. The drug is usually used orally or peripherally.
Silica porous nanoparticles were used in this research as the drug carrier to produce the desired nanodrug system. Among the important effects of the nanodrug on the treatment of cancer, mention can be made of reducing therapeutic costs and the side effects.
Silica nanoparticles are biodegradable and non-toxic, although they have many chemical abilities to be used in the designing of drug delivery nanosystems.
Silica porous nanoparticles were firstly designed and synthesized in this research. The nanoparticles were modified by polyethylene glycol and other organic functional groups, and then they were characterized. In the end, curcumin was loaded in the nanoparticles.
Results of the research have been published in European Journal of Medicinal Chemistry, vol. 83, issue 1, 2014, pp. 646-654.
####
For more information, please click here
Copyright © Fars News Agency
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
| Related News Press |
News and information
Oxford Instruments announces release of new dilution refrigerator - Proteox: Opening the door for a new direction in dilution refrigerator development February 28th, 2020
Breaking the temperature barrier in small-scale materials testing February 28th, 2020
An 'exceptionally stable' single-atom catalyst: Single platinum atoms stabilized in C12A7 crystals February 26th, 2020
180 Degree Capital Corp. Reports 15.9% Annual Increase and 0.3% Quarter Increase in Net Asset Value Per Share to $3.06 as of December 31, 2019 February 24th, 2020
Cancer
How to keep boron inside cells during radiotherapy: a simple novel approach to cancer treatment January 24th, 2020
Let the europium shine brighter January 21st, 2020
Copper-based nanomaterials can kill cancer cells in mice January 10th, 2020
Tech company NANOBIOTIX announces late-stage registration trial and global development plan for 2020 January 8th, 2020
Nanomedicine
Gold nanoclusters: new frontier for developing medication for treatment of Alzheimer's disease February 14th, 2020
Nanotech company granted FDA Fast Track for treatment of head & neck cancer February 10th, 2020
Discoveries
Breaking the temperature barrier in small-scale materials testing February 28th, 2020
An 'exceptionally stable' single-atom catalyst: Single platinum atoms stabilized in C12A7 crystals February 26th, 2020
The Human Brain/Cloud Interface Research Paper has been Published! February 22nd, 2020
Announcements
Oxford Instruments announces release of new dilution refrigerator - Proteox: Opening the door for a new direction in dilution refrigerator development February 28th, 2020
Breaking the temperature barrier in small-scale materials testing February 28th, 2020
An 'exceptionally stable' single-atom catalyst: Single platinum atoms stabilized in C12A7 crystals February 26th, 2020
180 Degree Capital Corp. Reports 15.9% Annual Increase and 0.3% Quarter Increase in Net Asset Value Per Share to $3.06 as of December 31, 2019 February 24th, 2020
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Breaking the temperature barrier in small-scale materials testing February 28th, 2020
An 'exceptionally stable' single-atom catalyst: Single platinum atoms stabilized in C12A7 crystals February 26th, 2020
The Human Brain/Cloud Interface Research Paper has been Published! February 22nd, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||